Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Natural Remedies

GTx's Toremifene 80 Mg Increased Bone Mineral Density In Multiple Clinically Relevant Subpopulations Of Prostate Cancer Patients
GTx, Inc. (Nasdaq: GTXI) announced the presentation of data demonstrating that toremifene 80 mg treatment compared to placebo increased bone mineral density (BMD) in multiple clinically relevant subpopulations of men with prostate cancer on androgen deprivation therapy (ADT). The data, an analysis of results of the recent Phase III clinical trial evaluating toremifene 80 mg for the prevention of bone fractures and treatment of other estrogen deficiency side effects of androgen deprivation therapy in men with prostate cancer, were presented yesterday at the 2009 Annual Meeting of the American Society of Clinical Oncology.
generic viagra online
Digital Mammography And Clinical Review Display Units Energising The European Markets For Medical Imaging Display Monitors, Finds Frost & Sullivan
Diagnostic display monitors have experienced slow growth in 2007 due to picture archiving and communication system (PACS) installations across radiology departments of European hospitals having reached saturation. However, favourable regulations mandating the sales of 5MP displays for digital mammography have ensured high-volume sales in several European countries. The increasing demand for clinical review display monitors from private practitioners has also ensured very high growth rates for medical imaging display monitors.
News of the day
Schizophrenia Linked For First Time To Chromosome Region In Study Led By Stanford Scientists
Stanford University School of Medicine scientists have played a major role in an international effort that has shown, for the first time, that modern genetic technologies can solve the riddle of how gene variations lead to schizophrenia.
Endocrinology

Male Circumcision Does Not Appear To Reduce HIV Transmission Risk To Female Partners

Although several studies have shown that circumcision, removal of the foreskin which contains cells that are particularly susceptible to HIV, appears to reduce a man"s risk of contracting HIV from his female sex partner, it does not reduce the female sex partners" risk of contracting the virus, according to a study in the Lancet, Reuters reports. Maria Wawer of Johns Hopkins University and colleagues in Uganda followed 922 HIV-positive, uncircumcised men ages 15 to 49. Some of the men immediately underwent a circumcision, and some had the procedure two years later. The researchers also followed 163 female partners of the men.The researchers decided to end the study early when they found that male circumcision did not convey the expected benefits to women. The study also found that men"s partners were no less likely to contract other sexually transmitted infections, except for trichomonas.However, based on observational studies, researchers say that circumcision is so effective in protecting men that it will still likely benefit women indirectly by reducing circulation of the virus in general (Fox, Reuters, 7/16). Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women"s Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women"s Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company. © 2009 The Advisory Board Company. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009